Numeric Investors’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$451K Sell
12,000
-2,400
-17% -$88.1K ﹤0.01% 915
2017
Q3
$525K Buy
+14,400
New +$549K ﹤0.01% 872
2016
Q3
Sell
-50,400
Closed -$1.68M 1096
2016
Q2
$1.68M Sell
50,400
-89,700
-64% -$3.07M 0.01% 478
2016
Q1
$4.12M Buy
140,100
+129,600
+1,234% +$3.58M 0.04% 309
2015
Q4
$276K Sell
10,500
-18,300
-64% -$475K ﹤0.01% 880
2015
Q3
$682K Sell
28,800
-2,159,700
-99% -$52.1M 0.01% 634
2015
Q2
$52M Sell
2,188,500
-1,444,200
-40% -$32.6M 0.6% 41
2015
Q1
$86.3M Sell
3,632,700
-370,200
-9% -$8.31M 1.06% 21
2014
Q4
$85M Buy
4,002,900
+1,393,350
+53% +$28M 1.1% 19
2014
Q3
$44.4M Buy
2,609,550
+2,521,950
+2,879% +$39.8M 0.66% 44
2014
Q2
$1.25M Buy
87,600
+48,600
+125% +$659K 0.02% 389
2014
Q1
$482K Buy
39,000
+7,200
+23% +$83.1K 0.01% 596
2013
Q4
$349K Buy
+31,800
New +$358K 0.01% 665

Other funds holding EW

Numeric Investors's EW Position: Q4 2017 in Review

Numeric Investors reduced its Edwards Lifesciences (EW) stake by 17% in Q4 2017, selling an estimated $88.1K and leaving 12,000 shares worth $451K. The position accounts for ﹤0.01% of the portfolio, ranked #915.

Numeric Investors first reported a position in EW in Q4 2013 and has held it in 13 quarters since. The position peaked at $86.3M in Q1 2015. 772 funds tracked by Wall St. Rank hold EW as of Q4 2017.

  • Numeric Investors held 12,000 shares of Edwards Lifesciences worth $451K as of Q4 2017.
  • Numeric Investors sold 2,400 Edwards Lifesciences shares in Q4 2017, an estimated $88.1K.
  • Edwards Lifesciences made up ﹤0.01% of Numeric Investors's portfolio in Q4 2017, its #915 holding.
  • Numeric Investors first reported a position in Edwards Lifesciences in Q4 2013 and has held it in 13 quarters since.
  • Numeric Investors's Edwards Lifesciences position peaked at $86.3M in Q1 2015.
  • 772 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2017.

Based on Numeric Investors's 13F filing for Q4 2017, filed 14 Feb 2018.